Literature DB >> 21178299

Genetic variability and haplotype profile of MDR1 (ABCB1) in Roma and Hungarian population samples with a review of the literature.

Csilla Sipeky1, Veronika Csongei, Luca Jaromi, Eniko Safrany, Anita Maasz, Istvan Takacs, Judit Beres, Lajos Fodor, Melinda Szabo, Bela Melegh.   

Abstract

The genetic variability, haplotype profile and ethnic differences of MDR1 polymorphisms in healthy Roma and Hungarian populations were analyzed and the results were compared with those of other populations available from the literature. Healthy subjects (465 Roma and 503 Hungarian) were genotyped for C1236T, G2677T/A and C3435T variants of MDR1 by PCR-RFLP assay. Differences were found between the Roma and Hungarian populations in the frequencies of MDR1 1236 CC (20.7 vs. 33.2%) and TT genotypes (30.8 vs. 21.9%), in T allele frequency (0.551 vs. 0.443) (p < 0.002), and in 3435T allele frequency (0.482 vs. 0.527, p < 0.04). Furthermore, the frequency of CGC, CGT and CTT haplotypes was significantly higher in the Hungarian population than in Roma (41.4 vs. 35.3%, 9.04 vs. 6.02% and 2.88 vs. 1.08%, respectively; p < 0.009), whereas the frequency of TGC and TTC haplotypes was higher in the Roma population than in the Hungarian (7.31 vs. 1.68% and 6.67 vs. 2.08%, respectively; p < 0.001). The prevalence of MDR1 polymorphisms in the Hungarian population is similar to that of other European populations; however, some differences were observed in the haplotype structures. In contrast, the Roma population differs from Hungarians, from Caucasians and from populations from India in the incidence of MDR1 common variants and haplotypes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178299     DOI: 10.2133/dmpk.dmpk-10-sc-068

Source DB:  PubMed          Journal:  Drug Metab Pharmacokinet        ISSN: 1347-4367            Impact factor:   3.614


  16 in total

Review 1.  Personalized medicine: is it a pharmacogenetic mirage?

Authors:  Rashmi R Shah; Devron R Shah
Journal:  Br J Clin Pharmacol       Date:  2012-10       Impact factor: 4.335

2.  Marked Differences of Haplotype Tagging SNP Distribution, Linkage, and Haplotype Profile of APOA5 Gene in Roma Population Samples.

Authors:  Katalin Sumegi; Balazs Duga; Bela I Melegh; Zsolt Banfai; Erzsebet Kovesdi; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2017-01-19       Impact factor: 3.201

3.  Genetic variability and haplotype profile of MDR1 in Saudi Arabian males.

Authors:  Abdullah M Al-Mohizea; Khalid M Alkharfy; Khawla M Bagulb; Amal M Alghamdi; Fahad I Al-Jenoobi; Saleh Al-Muhsen; Rabih Halwani; Mohammad Khalid Parvez; M Khalid Parvez; Mohammed S Al-Dosari
Journal:  Mol Biol Rep       Date:  2012-10-07       Impact factor: 2.316

Review 4.  High prevalence of CYP2C19*2 allele in Roma samples: study on Roma and Hungarian population samples with review of the literature.

Authors:  Csilla Sipeky; Agnes Weber; Melinda Szabo; Bela I Melegh; Ingrid Janicsek; Greta Tarlos; Istvan Szabo; Katalin Sumegi; Bela Melegh
Journal:  Mol Biol Rep       Date:  2013-05-05       Impact factor: 2.316

5.  Lower carrier rate of GJB2 W24X ancestral Indian mutation in Roma samples from Hungary: implication for public health intervention.

Authors:  Csilla Sipeky; Petra Matyas; Marton Melegh; Ingrid Janicsek; Renata Szalai; Istvan Szabo; Reka Varnai; Greta Tarlos; Alma Ganczer; Bela Melegh
Journal:  Mol Biol Rep       Date:  2014-06-27       Impact factor: 2.316

6.  ABCB1 C3435T polymorphism influences the risk for Alzheimer's disease.

Authors:  Ágnes Fehér; Anna Juhász; Magdolna Pákáski; János Kálmán; Zoltán Janka
Journal:  J Mol Neurosci       Date:  2014-10-02       Impact factor: 3.444

7.  Association between MDR1 gene polymorphisms and the risk of Crohn's disease in a cohort of Algerian pediatric patients.

Authors:  Amira Bouzidi; Hamida Mesbah-Amroun; Aziza Boukercha; Fadila Benhassine; Réda Belboueb; Karima Berkouk; Wassila Messadi; Chafia Touil-Boukoffa
Journal:  Pediatr Res       Date:  2016-09-07       Impact factor: 3.756

8.  Multidrug resistance 1 (MDR1) 3435C>T gene polymorphism influences the clinical phenotype and methotrexate-induced adverse events in South Indian Tamil rheumatoid arthritis.

Authors:  Niveditha Muralidharan; Paul T Antony; Vikramraj K Jain; Christina Mary Mariaselvam; Vir Singh Negi
Journal:  Eur J Clin Pharmacol       Date:  2015-06-14       Impact factor: 2.953

Review 9.  IL-1β biological treatment of familial Mediterranean fever.

Authors:  Alessandra Soriano; Elena Verecchia; Antonella Afeltra; Raffaele Landolfi; Raffaele Manna
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

10.  Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.

Authors:  Dalma Varszegi; Balazs Duga; Bela I Melegh; Katalin Sumegi; Peter Kisfali; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2013-12-05       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.